The Global Desalting and Buffer Exchange Market is expected to grow significantly over the forecast period. It is anticipated that the market held a market value of USD 615.20 million in 2017 and is projected to grow at a CAGR of 10.5% over the forecast period. Desalting is a separation process removes soluble low molecular weight substances from protein and nucleic acid samples. Buffer exchange is the replacement of one set of buffer salts with another set.
Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/6633
Additionally, during the preparation of biological samples, buffer exchange is an essential step, as it prepares the sample for downstream applications. The factors such as growing demand for monoclonal antibodies, increasing research and development expenditure by the biopharmaceutical companies, and growing focus on proteomic and genomic research is expected to drive the market growth over the forecast period. According to the Office for National Statistics, gross domestic expenditure on R&D was Euro 33.1 billion (USD 35.2 billion) in 2016. Despite the drivers, the lack of skilled professionals is expected to restrain the market growth.
Segmentation
The Global Desalting and Buffer Exchange Market has been segmented into technique, product, and application. On the basis of technique, the market has been segmented into filtration, chromatography, and precipitation. The filtration segment has been further segmented into ultrafiltration and dialysis. The chromatography segment has been segmented into size-exclusion chromatography and others.
The market, by product, has been segmented into kits, cassettes, filter plates, spin columns, membrane filters, and others.
The market, by application, has been segmented into bioprocess applications and diagnostic applications. The bioprocess segment is expected to account for the largest market share in 2017. The market growth of the segment is attributed to the increasing demand for biopharmaceutical products.
The market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The desalting and buffer exchange market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada.
The European desalting and buffer exchange market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.
The desalting and buffer exchange market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The desalting and buffer exchange market in the Middle East & Africa has been segmented into the Middle East and Africa.
Key Players
Merck KGaA, GE Healthcare, Sartorius AG, Thermo Fisher Scientific, Danaher Corporation, Agilent Technologies, Inc., Bio-Rad Laboratories, Avantor, Repligen Corporation, Bio-works Technologies Ab, Phynexus, Inc., and Norgen Biotek Corp. are some of the key players in the global desalting and buffer exchange market.
Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/desalting-and-buffer-exchange-market-6633
No comments:
Post a Comment